List of quality statements
Statement 1. People with suspected colorectal cancer without major comorbidity are offered diagnostic colonoscopy.
Statement 2. People with colon cancer are offered contrast-enhanced computed tomography (CT) of the chest, abdomen and pelvis to determine the stage of the disease.
Statement 3. People with rectal cancer are offered contrast-enhanced computed tomography (CT) of the chest, abdomen and pelvis to determine the stage of the disease, and pelvic magnetic resonance imaging (MRI) to assess the risk of local recurrence.
Statement 4. People with rectal cancer are offered a preoperative treatment strategy appropriate to their risk of local disease recurrence.
Statement 5. People with locally excised, pathologically confirmed stage I colorectal cancer whose tumour had involved resection margins (less than 1 mm) are offered further surgery or active monitoring.
Statement 6. People with a contrast-enhanced computed tomography (CT) of the chest, abdomen and pelvis suggesting liver metastatic colorectal cancer have their scans reviewed by the hepatobiliary multidisciplinary team to decide whether further imaging is needed to confirm suitability for surgery.
Statement 7. People with locally advanced or metastatic colorectal cancer whose disease progresses after first-line systemic anticancer therapy are offered second-line systemic anticancer therapy if they are able to tolerate it.
Statement 8. People free from disease after treatment for colorectal cancer are offered regular surveillance.
In addition, quality standards that should also be considered when commissioning and providing a high-quality colorectal cancer service are listed in Related NICE quality standards.